7Baggers

We provide you with 20 years of free, institutional-grade data for SNSE stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of SNSE. Explore the full financial landscape of SNSE stock.

Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
NameActionSharesAvg PriceAmountReported Date
Login to see more insider transactions
The information provided in this report about SNSE stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Sensei Biotherapeutics, Inc
(NASDAQ:SNSE) 

SNSE stock logo

Sensei Biotherapeutics is developing a pipeline of medicines designed to fulfill the substantial potential of the immune system to defeat cancer.

Founded: 1999
CEO: John K Celebi  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends